Levine James E.
Insider CIK 1463151 · VRNM President & CEO, Director · KZIA Chief Financial Officer · CRDF Chief Financial Officer · CDTX Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KZIA KAZIA THERAPEUTICS LTD | A Award deriv | 2026-06-19 | 2026-06-23 | 200,000 | — | $0 | 200,000 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | A Award deriv | 2025-03-11 | 2025-03-13 | 332,621 | — | $0 | 1,295,117 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | P Buy | 2024-12-18 | 2024-12-18 | 2,400 | $5.00 | $12.0K | 67,716 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | P Buy | 2024-12-17 | 2024-12-18 | 2,752 | $5.42 | $14.9K | 65,316 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | P Buy | 2024-12-16 | 2024-12-18 | 2,564 | $3.83 | $9.8K | 62,564 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | A Award deriv | 2024-03-07 | 2024-03-07 | 205,008 | — | $0 | 962,496 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | A Award deriv | 2023-03-15 | 2023-03-16 | 197,472 | — | $0 | 757,488 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | P Buy | 2022-09-16 | 2022-09-19 | 30,000 | $1.56 | $46.8K | 60,000 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | A Award deriv | 2022-03-09 | 2022-03-10 | 170,016 | — | $0 | 560,016 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | P Buy | 2021-09-10 | 2021-09-13 | 5,000 | $6.32 | $31.6K | 30,000 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | P Buy | 2021-09-10 | 2021-09-13 | 5,000 | $6.35 | $31.8K | 25,000 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | P Buy | 2021-09-10 | 2021-09-13 | 10,000 | $6.38 | $63.8K | 20,000 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | P Buy | 2021-09-10 | 2021-09-13 | 5,000 | $6.75 | $33.8K | 10,000 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | P Buy | 2021-09-10 | 2021-09-13 | 5,000 | $6.62 | $33.1K | 5,000 | SEC↗ |
| CRDF Cardiff Oncology, Inc. | A Award deriv | 2021-07-12 | 2021-07-12 | 390,000 | — | $0 | 390,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2021-03-17 | 2021-03-19 | 130,000 | — | $0 | 130,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | P Buy | 2020-11-10 | 2020-11-12 | 50,000 | $2.01 | $100.5K | 50,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | M Exercise deriv | 2020-03-19 | 2020-03-23 | 110,000 | — | $0 | 110,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award | 2020-03-19 | 2020-03-23 | 25,000 | — | $0 | 61,891 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | X Exercise deriv | 2020-01-28 | 2020-01-30 | 6,891 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | X Exercise | 2020-01-28 | 2020-01-30 | 6,891 | $2.51 | $17.3K | 211,891 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | P Buy | 2019-09-24 | 2020-03-23 | 30,000 | $1.91 | $57.3K | 30,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | P Buy | 2019-09-24 | 2019-09-26 | 30,000 | $1.91 | $57.3K | 205,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2018-12-03 | 2018-12-04 | 175,000 | — | $0 | 175,000 | SEC↗ |
| VRNM VERENIUM CORP | D To issuer deriv | 2013-10-31 | 2013-11-04 | 20,000 | — | $0 | 0 | SEC↗ |
| VRNM VERENIUM CORP | D To issuer deriv | 2013-10-31 | 2013-11-04 | 34,796 | — | $0 | 0 | SEC↗ |
| VRNM VERENIUM CORP | D To issuer deriv | 2013-10-31 | 2013-11-04 | 16,875 | — | $0 | 0 | SEC↗ |
| VRNM VERENIUM CORP | D To issuer deriv | 2013-10-31 | 2013-11-04 | 24,063 | — | $0 | 0 | SEC↗ |
| VRNM VERENIUM CORP | D To issuer deriv | 2013-10-31 | 2013-11-04 | 13,125 | — | $0 | 0 | SEC↗ |
| VRNM VERENIUM CORP | D To issuer deriv | 2013-10-31 | 2013-11-04 | 10,937 | — | $0 | 0 | SEC↗ |
| VRNM VERENIUM CORP | D To issuer deriv | 2013-10-31 | 2013-11-04 | 444 | — | $0 | 0 | SEC↗ |
| VRNM VERENIUM CORP | D To issuer deriv | 2013-10-31 | 2013-11-04 | 129,695 | — | $0 | 0 | SEC↗ |
| VRNM VERENIUM CORP | D To issuer deriv | 2013-10-31 | 2013-11-04 | 20,833 | — | $0 | 0 | SEC↗ |
| VRNM VERENIUM CORP | D To issuer deriv | 2013-10-31 | 2013-11-04 | 84,556 | — | $0 | 0 | SEC↗ |
| VRNM VERENIUM CORP | D To issuer | 2013-10-31 | 2013-11-04 | 109,166 | $4.00 | $436.7K | 0 | SEC↗ |
| VRNM VERENIUM CORP | A Award deriv | 2013-08-01 | 2013-08-02 | 24,063 | — | $0 | 24,063 | SEC↗ |
| VRNM VERENIUM CORP | A Award deriv | 2013-08-01 | 2013-08-02 | 10,937 | — | $0 | 10,937 | SEC↗ |
| VRNM VERENIUM CORP | A Award deriv | 2012-08-02 | 2012-08-03 | 16,875 | $4.23 | $71.4K | 16,875 | SEC↗ |
| VRNM VERENIUM CORP | A Award deriv | 2012-08-02 | 2012-08-03 | 13,125 | $4.23 | $55.5K | 13,125 | SEC↗ |
| VRNM VERENIUM CORP | P Buy | 2012-05-15 | 2012-05-16 | 4,994 | $3.65 | $18.2K | 109,166 | SEC↗ |